Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Bioengineering and Biotherapies, September 2007, Nancy
Article type: Research Article
Authors: Etienne, Stéphanie | Gaborit, Nadège | Henrionnet, Christel | Pinzano, Astrid | Galois, Laurent | Netter, Patrick | Gillet, Pierre | Grossin, Laurent
Affiliations: Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS – Nancy Université, Faculté De Médecine, UMR 7561 CNRS – Nancy Université, Vandœuvre lès Nancy, France
Note: [] Equal contribution to this work.
Note: [] Address for correspondence: Pierre Gillet, Physiopathologie et Pharmacologie Articulaires, Faculté De Médecine, UMR 7561 CNRS – Nancy Université, Avenue De La Forêt De Haye Bp 184, F 54505 Vandœuvre lès Nancy, France. E-mail: P.Gillet@Chu-Nancy.Fr.
Abstract: Aim: to determine if chondrocytic Hsp70 induction, via intra-articular injections of a reversible proteasome inhibitor (MG132), can protect articular chondrocytes from cellular death in experimental rat OA knee induced surgically by anterior cruciate ligament transection (ACLT). Materials and methods: ACLT was performed on D0. Histological lesions in naive (sham) controls (ACLT+saline) and treated (ACLT+MG132) rats were assessed according to Mankin's score. Repeated intra-articular injections (1.5 μM MG132 or saline were performed on D1, D7, D14 and D21. Rats were sacrificed sequentially on D7, D14 and D28. Detection of active caspase-3 and protein expression of Hsp70 was also determined on D7, D14 and D28 by immunostaining methods. Results: MG132 significantly reduced OA lesions on D28 in the MG132 treated group. The expression of Hsp70 increased 11-fold in the MG132-treated group versus 2-3-fold in ACLT-control rats on D28. Concomitantly, cells expressing caspase-3 increased 4-fold in ACLT model and decreased 2-fold with MG132 treatment. Conclusions: Intra-articular induction of Hsp70 by MG132 could be a safe and interesting tool in chondrocytes protection from cellular injuries and thus might be a novel chondroprotective modality in rat OA.
DOI: 10.3233/BME-2008-0534
Journal: Bio-Medical Materials and Engineering, vol. 18, no. 4-5, pp. 253-260, 2008
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl